Three more retractions for former record-holder Boldt, maybe more to come

m_cover

Justus Liebig University in Germany has been investigating concerns that Joachim Boldt, number two on the Retraction Watch Leaderboard and now up to 92 retractions, may have “manipulated” more data than previously believed.

Until now, the vast majority of Boldt’s retractions were thought to have involved inadequate ethics approval. However, new retraction notices for Boldt’s research suggest that there’s evidence the researcher also engaged in significant data manipulation.

The first retraction from the university investigation emerged last year. Two of three new notices cite the investigation specifically, and an informant at the university told us that there are more retractions to come.

Here are the retracted papers that are freshly on the record, starting with an August retraction for a 1991 Anesthesiology paper (cited 37 times, according to Thomson Scientific’s Web of Knowledge):

Continue reading Three more retractions for former record-holder Boldt, maybe more to come

Drugmaker accused of omitting side effect data from 2003 Risperdal paper

cover7607A 2003 paper may have left out potentially “significant” data on the long-term side-effects of an antipsychotic drug used in children, according to a former head of the U.S. Food and Drug Administration.

As reported by the Toronto StarDavid Kessler is alleging that Janssen, the maker of Risperdal (and owned by Johnson & Johnson), omitted data about the risks of the drug: In particular, that boys who use it over a long period may be at risk of growing breasts.

There’s anecdotal evidence of the side effect. One family claimed the drug had caused their son to grow a pair of 46 DD-sized breasts in a lawsuit against Johnson & Johnson, reported the Wall Street Journal in February. They won, to the tune of $2.5 million. The suit is apparently just one of 1,200 like it.

The abstract of the paper, “Prolactin levels during long-term risperidone treatment in children and adolescents,” published in The Journal of Clinical Psychiatry, suggests that levels of a key hormone aren’t a problem in the long term:

Continue reading Drugmaker accused of omitting side effect data from 2003 Risperdal paper

“Gap in the proof” deletes math paper

BAZThe author of a paper on the properties of a vector space is retracting it from The Bulletin of the Australian Mathematical Society after a “false application” of a theorem led to a “gap in the proof.”

Here’s the abstract of “On a Weakly Uniformly Rotund Dual of a Banach Space,” in full:

Every Banach space with separable second dual can be equivalently renormed to have weakly uniformly rotund dual. Under certain embedding conditions a Banach space with weakly uniformly rotund dual is reflexive.

And the retraction note, published in the August issue of the journal:

Continue reading “Gap in the proof” deletes math paper

Authors withdraw immunology study, no reasons given

Journal of Biological Chemistry1Researchers have withdrawn a 2010 article in the Journal of Biological Chemistry about an immune regulator.

The paper was pulled without any explanation (in standard JBC style). Here’s the complete notice:

This article has been withdrawn by the authors.

The study’s authors were based out of Shandong University Medical School, Jinan General Hospital of Jinan Command and Duke University Medical Center.

Two of the authors have had previous papers retracted.

Continue reading Authors withdraw immunology study, no reasons given

The worm has turned: Nematode study retracted for misidentification

toxicol patholThe authors of a paper on parasitic nematodes have retracted the article because they misidentified the organism in question, so “the possibility of misleading readers was high.”

The paper, “Histopathological features of Capillaria hepatica infection in laboratory rabbits,” appeared in Toxicologic Pathology in 2009 and came from a lab at Huntingdon Life Sciences, in Cambridgeshire, England.

According to the abstract: Continue reading The worm has turned: Nematode study retracted for misidentification

Fruit fly paper retracted when gene turns out not to code for a protein as claimed

1.cover-sourceThe Journal of Insect Science is retracting a paper on the genetics of a fruit fly after discovering one of the genes the authors sequenced doesn’t appear to code for a protein.

The paper, “Molecular phylogeny and identification of the peach fruit fly, Bactrocera zonata, established in Egypt” was published in 2011, and compared sequences of the Egyptian species to those from species in other regions. It has not yet been cited, according to Thomson Scientific’s Web of Knowledge.

Phyllis Weintraub, the editor-in-chief of the journal, told us she thinks that the paper’s fatal mistake stemmed from “bad science instead of deliberate falsification.”

The retraction notice should go live on the site today, according to Lisa Junker, director of publications and communications for the Entomological Society of America, which publishes the journal. Here’s the text:

Continue reading Fruit fly paper retracted when gene turns out not to code for a protein as claimed

“We copied verbatim”: Authors insist on retraction for their own spider paper

Journal of ArachnologyThe authors of a 2015 paper about non-native spider populations in Chile are retracting it from the Journal of Arachnology because they copied the introduction of a 2011 paper verbatim.

The retraction was triggered by the first author, who “insisted on a full retraction in lieu of milder remedies,” according to the journal’s editor-in-chief.

The paper, “Alien spiders in Chile: evaluating Darwin’s naturalization hypothesis,” tested Darwin’s hypothesis that introduced species that are phylogenetically distant from native animals are more likely to thrive. It was published in April. Authors Andrés Taucare-Ríos and Ramiro O. Bustamante are both based at the University of Chile in Santiago.

The notice reads:

Continue reading “We copied verbatim”: Authors insist on retraction for their own spider paper

Serbian journal cleans house with 16 retractions and 2 corrections after investigation

Archives of Biological SciencesEditors at the Archives of Biological Sciences, the official journal of Serbian Biological Society, have unleashed a flood of retractions and corrections as part of an effort to fix the mistakes of the former editorial board.

The fixes 16 retractions and two corrections, by our count are in response to a formal investigation that took place last year, and ended with a call for a two-year suspension of the journal’s funding and the resignation of key management figures, including the editor-in-chief, Božidar Ćurčić (who resigned after the announcement).

Goran Poznanović, the new editor-in-chief at ABS, told us that the journal is invested in cleaning up past mistakes and will investigate every request.

Continue reading Serbian journal cleans house with 16 retractions and 2 corrections after investigation

Canadian researchers in legal battle over investigation object to third retraction

The Journal of Clinical InvestigationA third retraction — and a notice of concern — have emerged from the investigation into a husband and wife research team at the University of Toronto that found evidence of faked images and duplicated data.

The problem, according to the latest retraction note for Sylvia Asa and Shereen Ezzat, in the Journal of Clinical Investigation: Portions of the RT-PCR gels “are duplicated in this publication and in a subsequent publication.” That subsequent publication is a 2003 paper that has received a Notice of Concern from the American Journal of Pathology.

According to the retraction note, co-author Gillian E. Wu of York University signed off on the journal’s decision, but Asa, Ezzat and second author Lei Zheng dissented to the retraction. Third author Xian-Feng Zhu couldn’t be reached. Although corresponding author Asa noted that “the initial screen of these samples support the conclusions made in the paper,” the JCI made its position perfectly clear in the note:

Continue reading Canadian researchers in legal battle over investigation object to third retraction

Voinnet notches second retraction, two more corrections

PNASOlivier Voinnet — a plant researcher who was recently suspended for two years from the Centre national de la recherche scientifique (CNRS) after an investigation by ETH Zurich and CNRS found evidence of misconduct — has issued his second retraction and two more corrections.

PNAS posted the retraction earlier this week for a 2006 article after an inspection of the raw data revealed “errors” in study images. Authors confirmed the issues in some figures and revealed “additional mounting mistakes” in others.

Voinnet has promised to issue retractions and corrections for every study that requires them. These latest notices bring our tally up to nine corrections, two retractions and one Expression of Concern.

Continue reading Voinnet notches second retraction, two more corrections